D. M. Whitelaw
- Topics
- Lymphoma Diagnosis and Treatment (3 papers)Cancer Treatment and Pharmacology (2 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers)
- Cited by
- ImmunologyVirologyHematology
- Partner nations
- CanadaSouth Africa
In The Last Decade
D. M. Whitelaw
17 papers receiving 283 citations
Peers
Comparison fields: 5 of 78
- Immunology 135
- Epidemiology 52
- Oncology 50
- Molecular Biology 41
- Hematology 37
Countries citing papers authored by D. M. Whitelaw
This map shows the geographic impact of D. M. Whitelaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. M. Whitelaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. M. Whitelaw more than expected).
Fields of papers citing papers by D. M. Whitelaw
This network shows the impact of papers produced by D. M. Whitelaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. M. Whitelaw. The network helps show where D. M. Whitelaw may publish in the future.
Co-authorship network of co-authors of D. M. Whitelaw
This figure shows the co-authorship network connecting the top 25 collaborators of D. M. Whitelaw. A scholar is included among the top collaborators of D. M. Whitelaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. M. Whitelaw. D. M. Whitelaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 30 | |
| 3 | 105 | |
| 4 | Hemoglobin values in aged men. | 12 |
| 5 | A comparison of nitrogen mustard and vinblastine sulfate in the treatment of patients with Hodgkin's disease. | 1 |
| 6 | Chromosome complement of lymph node cells in Hodgkin's disease. | 10 |
| 7 | Multiple primary carcinomas associated with Hodgkin's disease. | 15 |
| 8 | 21 | |
| 9 | The relation between lymphosarcoma and leukemia. | 3 |
| 10 | 84 | |
| 11 | 3 | |
| 12 | VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE. | 12 |
| 13 | Vincaleukoblastine in the treatment of malignant disease. | 9 |
| 14 | 6 | |
| 15 | Studies of erythrocyts survival in acute leukaemia. | 2 |
| 16 | Cavernous transformation of the portal vein in polycythaemia vera. | 1 |
| 17 | The haemophilic syndrome; a review of 27 cases. | 3 |
| 18 | Massive subcutaneous haemorrhage in polycythaemia vera. | 3 |
| 19 | 8 |
About D. M. Whitelaw
D. M. Whitelaw is a scholar working on Biological Psychiatry, Pathology and Forensic Medicine and Genetics, having authored 19 papers that have together received 337 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (135 citations), Virology (30 citations) and Hematology (37 citations). D. M. Whitelaw has collaborated with scholars based in Canada and South Africa. Frequent co-authors include J. Stanley Smith, Donald O. Anderson, Barbara E. Hazlett, R E Alison and Kenneth A. Evelyn. Their work appears in journals such as Blood, Journal of Cellular Physiology and American Journal of Physiology-Legacy Content.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.